Historical Stock Price
ETFs Holding BEAM »    BEAM Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/22/2021 $104.36 $119.23 $103.00 $110.41 1.02M
02/23/2021 $102.31 $103.32 $82.59 $96.48 2.70M
02/24/2021 $96.30 $101.85 $92.21 $97.03 1.32M
02/25/2021 $97.40 $99.45 $86.94 $88.52 1.66M
02/26/2021 $90.00 $92.98 $84.13 $89.13 1.25M
Beam Therapeutics is a biotechnology company. Co. is engaged in creating a class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. Co.'s base editors have two principal components that are fused together to form a single protein: a CRISPR protein, bound to a guide RNA, that utilizes the DNA-targeting ability of CRISPR, but modified to not cause a double-stranded break; and a base editing enzyme, such as a deaminase, which carries out the desired chemical modification of the target DNA base.
BEAM historical stock prices picture
Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on February 22, 2021, BEAM opened at $104.36, traded as high as $119.23 and as low as $103.00, and closed at $110.41. Trading volume was a total of 1.02M shares. On February 23, 2021, BEAM opened at $102.31, traded as high as $103.32 and as low as $82.59, and closed at $96.48. Trading volume was a total of 2.70M shares. On February 24, 2021, BEAM opened at $96.30, traded as high as $101.85 and as low as $92.21, and closed at $97.03. Trading volume was a total of 1.32M shares. On February 25, 2021, BEAM opened at $97.40, traded as high as $99.45 and as low as $86.94, and closed at $88.52. Trading volume was a total of 1.66M shares. On February 26, 2021, BEAM opened at $90.00, traded as high as $92.98 and as low as $84.13, and closed at $89.13. Trading volume was a total of 1.25M shares.

BEAM Historical Stock Prices By Date:

BEAM historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 02/28/2011
End date: 02/26/2021
Start price/share: $61.86
End price/share: $89.13
Starting shares: 161.66
Ending shares: 168.47
Dividends reinvested/share: $2.52
Total return: 50.16%
Average Annual Total Return: 4.15%
Starting investment: $10,000.00
Ending investment: $15,019.00
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/28/2011
End date: 02/26/2021
Start price/share: $61.86
End price/share: $89.13
Dividends collected/share: $2.52
Total return: 48.15%
Average Annual Total Return: 4.01%
Starting investment: $10,000.00
Ending investment: $14,818.28
Years: 10.00
Date Close
02/22/2021$110.41
02/23/2021$96.48
02/24/2021$97.03
02/25/2021$88.52
02/26/2021$89.13
BEAM is categorized under the Consumer sector; below are some other companies in the same sector:

BETR Historical Stock Prices
BGS Historical Stock Prices
BLBD Historical Stock Prices
BLDP Historical Stock Prices
BNNY Historical Stock Prices
BOBE Historical Stock Prices
BORN Historical Stock Prices
BRB Historical Stock Prices
BREW Historical Stock Prices
BRFS Historical Stock Prices

BEAM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.